Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3360915
Max Phase: Preclinical
Molecular Formula: C26H20ClN5O2S4
Molecular Weight: 598.20
Molecule Type: Small molecule
Associated Items:
ID: ALA3360915
Max Phase: Preclinical
Molecular Formula: C26H20ClN5O2S4
Molecular Weight: 598.20
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cccc(CSc2nnc(NC(=O)CSc3nc4ccc(NC(=O)c5ccccc5Cl)cc4s3)s2)c1
Standard InChI: InChI=1S/C26H20ClN5O2S4/c1-15-5-4-6-16(11-15)13-35-26-32-31-24(38-26)30-22(33)14-36-25-29-20-10-9-17(12-21(20)37-25)28-23(34)18-7-2-3-8-19(18)27/h2-12H,13-14H2,1H3,(H,28,34)(H,30,31,33)
Standard InChI Key: GLERSYALOFZOKS-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 598.20 | Molecular Weight (Monoisotopic): 597.0188 | AlogP: 7.39 | #Rotatable Bonds: 9 |
Polar Surface Area: 96.87 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 6.84 | CX Basic pKa: 1.07 | CX LogP: 7.63 | CX LogD: 7.03 |
Aromatic Rings: 5 | Heavy Atoms: 38 | QED Weighted: 0.14 | Np Likeness Score: -2.80 |
1. Hou X, Li R, Li K, Yu X, Sun JP, Fang H.. (2014) Fast identification of novel lymphoid tyrosine phosphatase inhibitors using target-ligand interaction-based virtual screening., 57 (22): [PMID:25372368] [10.1021/jm500692u] |
Source(1):